Cargando…

Mechanisms of kidney protection by intensive insulin therapy during critical illness

Detalles Bibliográficos
Autores principales:	Vanhorebeek, I, Ellger, B, Gunst, J, Boussemaere, M, Debaveye, Y, Rabbani, N, Thornalley, P, Schetz, M, Van den Berghe, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088522/ http://dx.doi.org/10.1186/cc6372

Ejemplares similares

Protection of mitochondria by intensive insulin therapy in critical illness: blood glucose control or insulin?
por: Vanhorebeek, I, et al.
Publicado: (2006)

Organ dysfunction in critical illness: impact of maintaining normoglycemia and glycemia-independent insulin actions
por: Ellger, B, et al.
Publicado: (2006)

Intensive insulin therapy and brief hypoglycemia do not increase neurological injury markers in critically ill children
por: Gielen, M, et al.
Publicado: (2010)

Regulation of type 1 deiodinase activity in prolonged critical illness
por: Debaveye, Y, et al.
Publicado: (2006)

Cortisol metabolism in critical illness: effects of intensive insulin therapy
por: Vanhorebeek, I, et al.
Publicado: (2005)

Insufficient activation of autophagy allows accumulation of cellular damage and may contribute to sustained organ failure in prolonged critically ill patients
por: Gunst, J, et al.
Publicado: (2011)

Impact of early versus late parenteral nutrition on morphological and molecular markers of atrophy and autophagy in skeletal muscle of critically ill patients
por: Vanhorebeek, I, et al.
Publicado: (2013)

Early detection of acute kidney injury during the first week of the ICU
por: Flechet, M, et al.
Publicado: (2015)

Effect of intensive insulin therapy on coagulation and fibrinolysis of respiratory critically ill patients
por: Langouche, L, et al.
Publicado: (2007)

Intensive insulin therapy in critically ill children: impact on blood glucose dynamics and its relation with mortality
por: Van Tornout, M, et al.
Publicado: (2013)

Fibroblast growth factor 21 response to critical illness: effect of blood glucose control and relation with mitochondrial dysfunction, the integrated stress response and survival
por: Thiessen, S, et al.
Publicado: (2015)

Effects of hyperglycemia and intensive insulin therapy on neurons and glial cells during critical illness
por: Sonneville, R, et al.
Publicado: (2011)

Estimated GFR versus creatinine clearance for evaluation of recovery from acute kidney injury
por: Timmermans, P, et al.
Publicado: (2014)

Insulin signaling in critical illness: intensive versus conventional insulin therapy
por: Langouche, L, et al.
Publicado: (2005)

Insufficient autophagy relates to mitochondrial dysfunction, organ failure and adverse outcome in an animal model of critical illness
por: Gunst, J, et al.
Publicado: (2012)

Strict blood glucose control with insulin improves hepatic mitochondrial ultrastructure and function in critical illness
por: Vanhorebeek, I, et al.
Publicado: (2004)

Impact of early parenteral nutrition on catabolism
por: Gunst, J, et al.
Publicado: (2013)

Recovery from AKI by KDIGO criteria
por: Schrijvers, D, et al.
Publicado: (2014)

Continuous Monitoring of Urine Output And Hemodynamic Disturbances Improves Early Detection of Acute Kidney Injury During First Week of Icu Stay
por: Flechet, M, et al.
Publicado: (2015)

Receptor for advanced glycation end products axis in critically ill patients
por: Ingels, C, et al.
Publicado: (2014)

Implementing intensive insulin therapy in daily practice reduces the incidence of critical illness polyneuropathy and/or myopathy
por: Berends, N, et al.
Publicado: (2008)

Effect of increasing intravenous glucose load in the presence of normoglycemia on outcome and metabolism in critically ill rabbits
por: Derde, S, et al.
Publicado: (2009)

Aberrant bone metabolism in critical illness
por: Vanhees, I, et al.
Publicado: (2012)

Reduced cortisol metabolism drives hypercortisolism in critical illness
por: Boonen, E, et al.
Publicado: (2012)

Neurocognitive consequences of iatrogenicphthalate exposure during critical illness in children: a study of a development and validation cohort
por: Verstraete, S, et al.
Publicado: (2015)

Alterations in adipose tissue during critical illness: an adaptive and protective response?
por: Langouche, L, et al.
Publicado: (2010)

Withholding parenteral nutrition during the first week of critical illness increases plasma bilirubin but lowers the incidence of cholestasis and gallbladder sludge
por: Vanwijngaerden, YM, et al.
Publicado: (2013)

Expression of glucose transporters in critical illness
por: Langouche, L, et al.
Publicado: (2006)

Results of an intensive insulin infusion protocol in diabetic and nondiabetic critically ill patients
por: Gomes, PN, et al.
Publicado: (2005)

Persisting neuroendocrine abnormalities and their association with physical impairment 5 years after critical illness
por: Vanhorebeek, Ilse, et al.
Publicado: (2021)

Severe hypoglycaemia during intensive insulin therapy: a rare event in critically ill patients
por: Kaukonen, M, et al.
Publicado: (2007)

Hyperglycemia and insulin resistance in COVID-19 versus non-COVID critical illness: Are they really different?
por: Langouche, Lies, et al.
Publicado: (2021)

Predictive value for weakness and 1-year mortality of screening electrophysiology tests in the ICU
por: Mechelen, H Van, et al.
Publicado: (2015)

Does artificial nutrition improve outcome of critical illness?
por: Schetz, Miet, et al.
Publicado: (2013)

Nutrition and autophagy deficiency in critical illness
por: Vanhorebeek, Ilse, et al.
Publicado: (2023)

Blood glucose amplitude variation: effects of intensive insulin therapy and relative association with mortality
por: Bekaert, E, et al.
Publicado: (2010)

Correction: Does artificial nutrition improve outcome of critical illness
por: Schetz, Miet, et al.
Publicado: (2013)

Which variables affect strict glycaemic control with intensive insulin therapy in postoperative/post-traumatic critically ill patients?
por: Weiss, M, et al.
Publicado: (2009)

Glargine insulin: an alternative to regular insulin for glycemic control in critically ill patients
por: Bhattacharyya, M, et al.
Publicado: (2007)

Critical illness induces nutrient-independent adipogenesis and accumulation of alternatively activated tissue macrophages
por: Marques, M, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_cokoteu4tbbvdqj5s8gdgu87c9